raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:98275

Myelodysplastic/myeloproliferative disease

Type
Clinical group
Group
Group of disorders
Status
active

This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enMyelodysplastic/myeloproliferative disease
frMaladie myélodysplasique/myéloproliférative
deMyeloproliferative/Myelodysplastische Krankheit
esEnfermedad mielodisplásica o mieloproliferativa
itMalattia mieloproliferativa o mielodisplastica
nlMyelodysplastische/myeloproliferatieve aandoening
ptDoença mielodisplástica ou mieloproliferativa
plChoroba mielodysplastyczna/mieloproliferacyjna
csMyelodysplastická/myeloproliferativní onemocnění
ukМієло диспластичне/мієлопроліферативне захворювання
zh骨髓增生异常/骨髓增殖性疾病
trMiyelodisplastik / miyeloproliferatif hastalık
2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
MONDO0020077Evalidated
MeSHD054437Evalidated
UMLSC1301355Evalidated
GARD9351Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

Children (4):

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Annual incidence1-9 / 1 000 0000.29 / 100 000EuropeValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card